Beyond diabetes: Testing long-term metformin adherence for dementia prevention. - Suppr | 超能文献

Beyond diabetes: Testing long-term metformin adherence for dementia prevention.

作者信息

Daly Timothy, Okholm Simon, Imbimbo Bruno P

机构信息

UMR 1219, Bordeaux Population Health, University of Bordeaux & INSERM, Bordeaux, France.

UMR 5164, ImmunoConcept, University of Bordeaux & CNRS, Bordeaux, France.

出版信息

Diabetes Obes Metab. 2025 Aug;27(8):4615-4616. doi: 10.1111/dom.16472. Epub 2025 May 23.

DOI:10.1111/dom.16472

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Beyond diabetes: Testing long-term metformin adherence for dementia prevention.

Diabetes Obes Metab. 2025 Aug;27(8):4615-4616. doi: 10.1111/dom.16472. Epub 2025 May 23.

2

Dementia risk in patients with type 2 diabetes: Comparing metformin with no pharmacological treatment.2 型糖尿病患者的痴呆风险：比较二甲双胍与无药物治疗。

Alzheimers Dement. 2023 Dec;19(12):5681-5689. doi: 10.1002/alz.13349. Epub 2023 Jul 3.

3

Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study.在糖尿病预防计划结果研究中观察二甲双胍的长期依从性。

BMJ Open Diabetes Res Care. 2020 Oct;8(1). doi: 10.1136/bmjdrc-2020-001537.

4

Metformin Adherence Reduces the Risk of Dementia in Patients With Diabetes: A Population-based Cohort Study.二甲双胍依从性降低糖尿病患者患痴呆症的风险：一项基于人群的队列研究。

Endocr Pract. 2023 Apr;29(4):247-253. doi: 10.1016/j.eprac.2023.01.007. Epub 2023 Jan 16.

5

AHRQ's comparative effectiveness research on oral medications for type 2 diabetes: a summary of the key findings.美国医疗保健研究与质量局关于2型糖尿病口服药物的比较疗效研究：主要研究结果总结

J Manag Care Pharm. 2012 Jan-Feb;18(1 Suppl A):1-22. doi: 10.18553/jmcp.2012.18.S1-A.1.

6

Metformin in the Prevention of Alzheimer's Disease and Alzheimer's Disease Related Dementias.二甲双胍在预防阿尔茨海默病和阿尔茨海默病相关痴呆中的应用。

J Prev Alzheimers Dis. 2023;10(4):706-717. doi: 10.14283/jpad.2023.113.

7

Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study.糖尿病预防计划结局研究中二甲双胍的长期安全性、耐受性和体重减轻。

Diabetes Care. 2012 Apr;35(4):731-7. doi: 10.2337/dc11-1299.

8

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.肥胖治疗的长期效果、经济后果及其对健康改善影响的系统评价

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. doi: 10.3310/hta8210.

9

Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.预防性药物的依从性：糖尿病预防计划中的预测因素与结果

Diabetes Care. 2006 Sep;29(9):1997-2002. doi: 10.2337/dc06-0454.

10

Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort study.2型糖尿病患者二甲双胍的依从性和停药情况：一项回顾性队列研究。

J Clin Transl Endocrinol. 2020 Apr 16;20:100225. doi: 10.1016/j.jcte.2020.100225. eCollection 2020 Jun.

引用本文的文献

1

Enhancing uptake of antidiabetic drugs to reduce cardiometabolic risk and dementia burden.提高抗糖尿病药物的摄取以降低心脏代谢风险和痴呆负担。

Alzheimers Dement. 2025 Sep;21(9):e70614. doi: 10.1002/alz.70614.